TY - JOUR
T1 - Prevention, detection, evaluation, and management of high blood pressure in adults
T2 - Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline
AU - 2017 ACC/AHA Hypertension Guideline Writing Committee
AU - Carey, Robert M.
AU - Whelton, Paul K.
AU - Aronow, Wilbert S.
AU - Casey, Donald E.
AU - Collins, Karen J.
AU - Himmelfarb, Cheryl Dennison
AU - DePalma, Sondra M.
AU - Gidding, Sammuel
AU - Jamerson, Kenneth A.
AU - Jones, Daniel W.
AU - McLaughlin, Eric J.
AU - Muntner, Paul
AU - Ovbiagele, Bruce
AU - Smith, Sidney C.
AU - Spencer, Crystal C.
AU - Stafford, Randall S.
AU - Taler, Sandra J.
AU - Thomas, Randall J.
AU - Williams, Kim A.
AU - Williamson, Jeff D.
AU - Wright, Jackson T.
N1 - Publisher Copyright:
© 2018 American College of Physicians.
PY - 2018/3/6
Y1 - 2018/3/6
N2 - Description: In November 2017, the American College of Cardiology (ACC) and the American Heart Association (AHA) released a clinical practice guideline for the prevention, detection, evaluation, and treatment of high blood pressure (BP) in adults. This article summarizes the major recommendations. Methods: In 2014, the ACC and the AHA appointed a multidis-ciplinary committee to update previous reports of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The committee reviewed literature and commissioned systematic reviews and meta-analyses on out-of-office BP monitoring, the optimal target for BP lowering, the comparative benefits and harms of different classes of antihypertensive agents, and the comparative benefits and harms of initiating therapy with a single antihypertensive agent or a combination of 2 agents. Recommendations: This article summarizes key recommendations in the following areas: BP classification, BP measurement, screening for secondary hypertension, nonpharmacologic therapy, BP thresholds and cardiac risk estimation to guide drug treatment, treatment goals (general and for patients with diabetes mellitus, chronic kidney disease, and advanced age), choice of initial drug therapy, resistant hypertension, and strategies to improve hypertension control.
AB - Description: In November 2017, the American College of Cardiology (ACC) and the American Heart Association (AHA) released a clinical practice guideline for the prevention, detection, evaluation, and treatment of high blood pressure (BP) in adults. This article summarizes the major recommendations. Methods: In 2014, the ACC and the AHA appointed a multidis-ciplinary committee to update previous reports of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The committee reviewed literature and commissioned systematic reviews and meta-analyses on out-of-office BP monitoring, the optimal target for BP lowering, the comparative benefits and harms of different classes of antihypertensive agents, and the comparative benefits and harms of initiating therapy with a single antihypertensive agent or a combination of 2 agents. Recommendations: This article summarizes key recommendations in the following areas: BP classification, BP measurement, screening for secondary hypertension, nonpharmacologic therapy, BP thresholds and cardiac risk estimation to guide drug treatment, treatment goals (general and for patients with diabetes mellitus, chronic kidney disease, and advanced age), choice of initial drug therapy, resistant hypertension, and strategies to improve hypertension control.
UR - http://www.scopus.com/inward/record.url?scp=85042470778&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042470778&partnerID=8YFLogxK
U2 - 10.7326/M17-3203
DO - 10.7326/M17-3203
M3 - Review article
C2 - 29357392
AN - SCOPUS:85042470778
SN - 0003-4819
VL - 168
SP - 351
EP - 358
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 5
ER -